In kickback scheme case involving fentanyl, former Arizona CEO to plead guilty
BOSTON — The former CEO of a company that produces a highly addictive fentanyl spray has agreed to plead guilty to participating in a scheme to pay kickbacks to doctors to boost prescriptions of the drug.
Former Insys Therapeutics CEO Michael Babich's guilty plea agreement was revealed by prosecutors in court documents filed this week.
Babich was among several executives of the Arizona-based company charged in the closely-watched case scheduled to go to trial next month. Insys founder John Kapoor and several others have pleaded not guilty.
They're charged with bribing doctors into prescribing large amounts of the powerful medication meant for cancer patients with severe pain.
Another Insys executive, Alec Burlakoff, pleaded guilty last month and is cooperating with prosecutors.
An email was sent to Babich's attorneys on Thursday.